
- /
- Supported exchanges
- / BE
- / GM0N.BE
GLOBUS MEDICAL-A (GM0N BE) stock market data APIs
GLOBUS MEDICAL-A Financial Data Overview
There is no Profile data available for GM0N.BE.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get GLOBUS MEDICAL-A data using free add-ons & libraries
Get GLOBUS MEDICAL-A Fundamental Data
GLOBUS MEDICAL-A Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GLOBUS MEDICAL-A News

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of ...


Globus Medical (NYSE:GMED) shareholders have endured a 16% loss from investing in the stock a year ago
Investors can approximate the average market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. That downside risk was reali...

Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?
Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Additionally, its string of product launches is highly promising to drive growth in th...

Globus Medical (GMED) Sees Sequential Revenue Surge, Citizens JMP Maintains Market Perform Rating
Globus Medical Inc. (NYSE:GMED) ranks among the best mid-cap stocks with huge upside potential. Following the publication of Globus Medical Inc. (NYSE:GMED)’s second-quarter 2025 results, Citizens J...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.